New England Journal of Medicine· 2016Q1

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients

Martin B. Leon, Craig R. Smith, Michael J. Mack, Raj Makkar et al.

5,046citations
Q1SCImago
2016year

Short summary

Transcatheter aortic-valve replacement (TAVR) was non-inferior to surgical valve replacement in intermediate-risk patients, with similar rates of death or disabling stroke at 2 years (19.3% vs. 21.1%).

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Cardiology and Cardiovascular Medicine

Cardiology and Cardiovascular MedicineMedicine